COVID-19: Use rapid tests to identify important biomarkers and predict the course of the disease

Whether it’s a lung embolism or a heart attack – an infection with coronavirus can have life-threatening consequences. But how badly will different patients be affected by COVID-19? This can be determined by certain biomarkers. nal von minden GmbH’s biomarker rapid tests from Germany deliver reliable results in just 15 minutes. An infection with coronavirus can run different courses. Some of those affected display no symptoms, whereas in other patients the course of the disease can be so severe that for some it is even fatal. Biomarkers serve as a quantifiable indicator for the presence and severity of an infection. They can be identified and evaluated using a blood sample.

Comunicat de presă furnizat şi asumat de APA-OTS

Citeşte comunicatul în întregime la adresa: http://comunicate.mediafax.biz/Pages/Public/Comunicate.aspx?comunicatId=14698